Entegris Reports Results for First Quarter Of 2021

Rhea-AI Summary

Entegris reported Q1 2021 sales of $512.8 million, a 24% increase year-over-year. GAAP net income reached $84.7 million ($0.62 per diluted share), while non-GAAP net income was $95.5 million ($0.70 per diluted share). The growth was fueled by strong demand in liquid filtration, advanced deposition materials, and specialty coatings. Additionally, the company anticipates second-quarter sales between $530 million and $545 million, with adjusted diluted earnings projected between $0.77 and $0.82.

Positive

• Q1 sales increased by 24% year-over-year to $512.8 million.
• GAAP net income was $84.7 million, or $0.62 per diluted share.
• Non-GAAP net income reached $95.5 million, or $0.70 per diluted share.
• Strong demand noted in liquid filtration and advanced deposition materials.
• Improved outlook for 2021 due to healthy semiconductor market.

Negative

• Integration costs of $2.0 million reported.
• GAAP net income slightly decreased from $86.6 million in the previous quarter.

Entegris, Inc. (NASDAQ: ENTG), today reported its financial results for the Company’s first quarter ended April 3, 2021.

First-quarter sales were $512.8 million, an increase of 24% from the same quarter last year. First-quarter GAAP net income was $84.7 million, or $0.62 per diluted share, which included $11.9 million of amortization of intangible assets and $2.0 million of integration costs. Non-GAAP net income was $95.5 million for the first-quarter and non-GAAP earnings per diluted share was $0.70.

Bertrand Loy, Entegris’ president and chief executive officer, said: “First quarter revenue growth was primarily driven by accelerating industry conditions and strong demand for our leading-edge solutions, especially in liquid filtration, advanced deposition materials and specialty coatings. We also continued to have strong demand for our Aramus high purity bags, which are used for the distribution and storage of the Covid-19 vaccine and other biologics.”

Mr. Loy added: “The semiconductor market looks very healthy across all customer segments, bolstered by a robust global GDP outlook and strong overall chip demand, driven by accelerated digitalization, 5G and high-performance computing. In addition, more wafers are being produced at the more advanced nodes where we enjoy greater Entegris content per wafer. Consequently, our outlook for the full year 2021 has improved significantly, and our teams are intensely focused on meeting the record level of demand for our products.”

Quarterly Financial Results Summary (in thousands, except percentages and per share data)
GAAP Results	April 03, 2021	March 28, 2020	December 31, 2020
Net sales	$512,844	$412,327	$517,594
Operating income	$113,978	$80,744	$113,228
Operating margin - as a % of net sales	22.2%	19.6%	21.9%
Net income	$84,676	$61,006	$86,624
Diluted earnings per common share	$0.62	$0.45	$0.63
Non-GAAP Results
Non-GAAP adjusted operating income	$128,036	$99,638	$126,945
Non-GAAP adjusted operating margin - as a % of net sales	25.0%	24.2%	24.5%
Non-GAAP net income	$95,513	$75,571	$97,123
Diluted non-GAAP earnings per common share	$0.70	$0.55	$0.71

Second-Quarter Outlook

For the second quarter ending July 3, 2021, the Company expects sales of $530 million to $545 million, net income of $77 million to $84 million and diluted earnings per common share between $0.56 and $0.61. On a non-GAAP basis, the company expects diluted earnings per common share to range from $0.77 to $0.82, reflecting net income on a non-GAAP basis in the range of $106 million to $113 million.

Segment Results

The Company reports its results in the following segments:

Specialty Chemicals and Engineered Materials (SCEM): SCEM provides high-performance and high-purity process chemistries, gases and materials, and safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.

Microcontamination Control (MC): MC offers solutions to filter and purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.

Advanced Materials Handling (AMH): AMH develops solutions to monitor, protect, transport, and deliver critical liquid chemistries, wafers, and other substrates for a broad set of applications in the semiconductor industry, life sciences and other high-technology industries.

First-Quarter Results Conference Call Details

Entegris will hold a conference call to discuss its results for the first quarter on Tuesday, April 27, 2021, at 9:00 a.m. Eastern Time. Participants should dial 800-437-2398 or +1 323-289-6576, referencing confirmation code 3813181. Participants are asked to dial in 5 to 10 minutes prior to the start of the call. For a replay of the call, please Click Here using passcode 3813181.

The call can also be accessed live and on-demand from the Entegris website. Go to https://investor.entegris.com/events-and-presentations and follow the link to the webcast. The on-demand playback will be available for six weeks after the conclusion of the teleconference.

Management’s slide presentation concerning the results for the first quarter, which may be referred to during the call, will be posted on the Investor Relations section of www.entegris.com Tuesday morning before the call.

About Entegris

Entegris is a world-class supplier of advanced materials and process solutions for the semiconductor and other high-tech industries. Entegris is ISO 9001 certified and has manufacturing, customer service and/or research facilities in the United States, Canada, China, France, Germany, Israel, Japan, Malaysia, Singapore, South Korea and Taiwan. Additional information can be found at www.entegris.com.

Non-GAAP Information

The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States (GAAP). Adjusted EBITDA, adjusted gross profit, adjusted segment profit, adjusted operating income, non-GAAP net income, non-GAAP adjusted operating margin and diluted non-GAAP earnings per common share, together with related measures thereof, are considered “non-GAAP financial measures” under the rules and regulations of the Securities and Exchange Commission. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. The Company provides supplemental non-GAAP financial measures to better understand and manage its business and believes these measures provide investors and analysts additional and meaningful information for the assessment of the Company’s ongoing results. Management also uses these non-GAAP measures to assist in the evaluation of the performance of its business segments and to make operating decisions. Management believes that the Company’s non-GAAP measures help indicate the Company’s baseline performance before certain gains, losses or other charges that may not be indicative of the Company’s business or future outlook, and that non-GAAP measures offer a more consistent view of business performance. The Company believes the non-GAAP measures aid investors’ overall understanding of the Company’s results by providing a higher degree of transparency for such items and providing a level of disclosure that will help investors generally understand how management plans, measures and evaluates the Company’s business performance. Management believes that the inclusion of non-GAAP measures provides greater consistency in its financial reporting and facilitates investors’ understanding of the Company’s historical operating trends by providing an additional basis for comparisons to prior periods. The reconciliations of GAAP gross profit to adjusted gross profit, GAAP segment profit to adjusted operating income, GAAP net income to adjusted operating income and adjusted EBITDA, GAAP net income and diluted earnings per common share to non-GAAP net income and diluted non-GAAP earnings per common share and GAAP outlook to non-GAAP outlook are included elsewhere in this release.

Forward-Looking Statements

This press release contains forward-looking statements. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include statements related to future period guidance; future sales, net income, net income per diluted share, non-GAAP EPS, non-GAAP net income, expenses and other financial metrics; the Company’s performance relative to its markets, including the drivers of such performance; the impact, financial or otherwise, of any organizational changes; market and technology trends, including the expected impact of the Covid-19 pandemic; the development of new products and the success of their introductions; the Company's capital allocation strategy, which may be modified at any time for any reason, including share repurchases, dividends, debt repayments and potential acquisitions; the impact of the acquisitions the Company has made and commercial partnerships the Company has established; the Company’s ability to execute on its strategies; and other matters. These statements involve risks and uncertainties, and actual results may differ materially from those projected in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks related to the Covid-19 pandemic on the global economy and financial markets, as well as on the Company, our customers and suppliers, which may impact our sales, gross margin, customer demand and our ability to supply our products to our customers; weakening of global and/or regional economic conditions, generally or specifically in the semiconductor industry, which could decrease the demand for the Company’s products and solutions; the Company’s ability to meet rapid demand shifts; the Company’s ability to continue technological innovation and introduce new products to meet customers' rapidly changing requirements; the Company’s concentrated customer base; the Company’s ability to identify, complete and integrate acquisitions, joint ventures or other transactions; the Company’s ability to effectively implement any organizational changes; the Company’s ability to protect and enforce intellectual property rights; operational, political and legal risks of the Company’s international operations; the Company’s dependence on sole source and limited source suppliers; the increasing complexity of certain manufacturing processes; raw material shortages, supply constraints and price increases; changes in government regulations of the countries in which the Company operates; fluctuation of currency exchange rates; fluctuations in the market price of the Company’s stock; the level of, and obligations associated with, the Company’s indebtedness; and other risk factors and additional information described in the Company’s filings with the Securities and Exchange Commission, including under the heading “Risks Factors" in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed on February 5, 2021, and in the Company’s other periodic filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

Entegris, Inc. and Subsidiaries Condensed Consolidated Statements of Operations (In thousands, except per share data) (Unaudited)
		Three months ended
		April 3, 2021			March 28, 2020			December 31, 2020
Net sales		$	512,844		$	412,327		$	517,594
Cost of sales			277,858			226,849			286,722
	Gross profit		234,986			185,478			230,872
Selling, general and administrative expenses			71,389			58,891			68,170
Engineering, research and development expenses			37,748			29,632			37,558
Amortization of intangible assets			11,871			16,211			11,916
	Operating income		113,978			80,744			113,228
Interest expense, net			11,581			10,238			12,133
Other expense (income), net			4,330			878			(5,305	)
	Income before income tax expense		98,067			69,628			106,400
Income tax expense			13,391			8,622			19,776
	Net income	$	84,676		$	61,006		$	86,624
Basic earnings per common share:		$	0.63		$	0.45		$	0.64
Diluted earnings per common share:		$	0.62		$	0.45		$	0.63
Weighted average shares outstanding:
	Basic		135,068			134,745			134,945
	Diluted		136,502			136,369			136,438

Entegris, Inc. and Subsidiaries Condensed Consolidated Balance Sheets (In thousands) (Unaudited)
				April 3, 2021			December 31, 2020
ASSETS
Current assets:
Cash and cash equivalents				$	548,520		$	580,893
Trade accounts and notes receivable, net					282,649			264,392
Inventories, net					358,819			323,944
Deferred tax charges and refundable income taxes					20,227			21,136
Other current assets					34,391			43,892
Total current assets					1,244,606			1,234,257
Property, plant and equipment, net					542,605			525,367
Other assets:
Right-of-use assets					48,057			45,924
Goodwill					747,518			748,037
Intangible assets, net					325,454			337,632
Deferred tax assets and other noncurrent tax assets					14,684			14,519
Other					10,615			11,960
Total assets				$	2,933,539		$	2,917,696
LIABILITIES AND EQUITY
Current liabilities
Accounts payable				$	93,045		$	81,618
Accrued liabilities					131,535			177,012
Income tax payable					41,691			43,996
Total current liabilities					266,271			302,626
Long-term debt, excluding current maturities					1,086,186			1,085,783
Long-term lease liability					42,953			39,730
Other liabilities					109,796			110,063
Shareholders’ equity					1,428,333			1,379,494
Total liabilities and equity				$	2,933,539		$	2,917,696

Entegris, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows (In thousands) (Unaudited)
	Three months ended
	April 3, 2021				March 28, 2020
Operating activities:
Net income	$	84,676			$	61,006
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		22,095				20,648
Amortization		11,871				16,211
Stock-based compensation expense		7,138				4,994
Other		8,166				5,563
Changes in operating assets and liabilities, net of effects of acquisitions:
Trade accounts and notes receivable		(21,564	)			(43,995	)
Inventories		(39,337	)			(18,205	)
Accounts payable and accrued liabilities		(28,591	)			(38,020	)
Income taxes payable, refundable income taxes and noncurrent taxes payable		(3,588	)			(225	)
Other		12,249				3,426
Net cash provided by operating activities		53,115				11,403
Investing activities:
Acquisition of property and equipment		(43,330	)			(22,585	)
Acquisition of business, net of cash acquired		—				(75,630	)
Other		72				5
Net cash used in investing activities		(43,258	)			(98,210	)
Financing activities:
Proceeds from short-term borrowings and long-term debt		—				217,000
Payments of short-term borrowings and long-term debt		—				(75,000	)
Payments for dividends		(10,908	)			(10,847	)
Issuance of common stock		1,572				551
Taxes paid related to net share settlement of equity awards		(15,038	)			(11,440	)
Repurchase and retirement of common stock		(15,000	)			(29,564	)
Deferred acquisition payments		—				(16,125	)
Other		(1	)			(2,890	)
Net cash (used in) provided by financing activities		(39,375	)			71,685
Effect of exchange rate changes on cash and cash equivalents		(2,855	)			(1,712	)
Decrease in cash and cash equivalents		(32,373	)			(16,834	)
Cash and cash equivalents at beginning of period		580,893				351,911
Cash and cash equivalents at end of period	$	548,520			$	335,077

Entegris, Inc. and Subsidiaries Segment Information (In thousands) (Unaudited)
	Three months ended
Net sales	April 3, 2021		March 28, 2020		December 31, 2020
Specialty Chemicals and Engineered Materials	$166,541		$144,214		$168,625
Microcontamination Control	207,099		159,261		205,626
Advanced Materials Handling	148,541		116,137		151,741
Inter-segment elimination	(9,337)		(7,285)		(8,398)
Total net sales	$512,844		$412,327		$517,594

	Three months ended
Segment profit	April 3, 2021			March 28, 2020			December 31, 2020
Specialty Chemicals and Engineered Materials	$	34,556		$	32,670		$	29,761
Microcontamination Control		70,566			50,167			71,691
Advanced Materials Handling		32,095			20,632			34,321
Total segment profit		137,217			103,469			135,773
Amortization of intangibles		11,871			16,211			11,916
Unallocated expenses		11,368			6,514			10,629
Total operating income	$	113,978		$	80,744		$	113,228

Entegris, Inc. and Subsidiaries Reconciliation of GAAP Gross Profit to Adjusted Gross Profit (In thousands) (Unaudited)
	Three months ended
	April 3, 2021				March 28, 2020				December 31, 2020
Net sales	$	512,844			$	412,327			$	517,594
Gross profit-GAAP	$	234,986			$	185,478			$	230,872
Adjustments to gross profit:
Charge for fair value mark-up of acquired inventory sold		—				361				—
Adjusted gross profit	$	234,986			$	185,839			$	230,872
Gross margin - as a % of net sales		45.8	%			45.0	%			44.6	%
Adjusted gross margin - as a % of net sales		45.8	%			45.1	%			44.6	%

Entegris, Inc. and Subsidiaries Reconciliation of GAAP Segment Profit to Adjusted Operating Income (In thousands) (Unaudited)
	Three months ended
Segment profit-GAAP	April 3, 2021			March 28, 2020			December 31, 2020
Specialty Chemicals and Engineered Materials (SCEM)	$	34,556		$	32,670		$	29,761
Microcontamination Control (MC)		70,566			50,167			71,691
Advanced Materials Handling (AMH)		32,095			20,632			34,321
Total segment profit		137,217			103,469			135,773
Amortization of intangible assets		11,871			16,211			11,916
Unallocated expenses		11,368			6,514			10,629
Total operating income	$	113,978		$	80,744		$	113,228

	Three months ended
Adjusted segment profit	April 3, 2021				March 28, 2020				December 31, 2020
SCEM segment profit	$	34,556			$	32,670			$	29,761
Severance and restructuring costs		47				174				155
Charge for fair value write-up of acquired inventory sold		—				235				—
SCEM adjusted segment profit	$	34,603			$	33,079			$	29,916
MC segment profit	$	70,566			$	50,167			$	71,691
Severance and restructuring costs		51				190				167
Charge for fair value write-up of acquired inventory sold		—				126				—
MC adjusted segment profit	$	70,617			$	50,483			$	71,858
AMH segment profit	$	32,095			$	20,632			$	34,321
Severance and restructuring costs		37				135				121
AMH adjusted segment profit	$	32,132			$	20,767			$	34,442
Unallocated general and administrative expenses	$	11,368			$	6,514			$	10,629
Unallocated deal and integration costs		(2,044	)			(1,479	)			(1,300	)
Unallocated severance and restructuring costs		(8	)			(344	)			(58	)
Adjusted unallocated general and administrative expenses	$	9,316			$	4,691			$	9,271
Total adjusted segment profit	$	137,352			$	104,329			$	136,216
Adjusted amortization of intangible assets		—				—				—
Adjusted unallocated general and administrative expenses		9,316				4,691				9,271
Total adjusted operating income	$	128,036			$	99,638			$	126,945

Entegris, Inc. and Subsidiaries Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA (In thousands) (Unaudited)
	Three months ended
	April 3, 2021				March 28, 2020				December 31, 2020
Net sales	$	512,844			$	412,327			$	517,594
Net income	$	84,676			$	61,006			$	86,624
Net income - as a % of net sales		16.5	%			14.8	%			16.7	%
Adjustments to net income:
Income tax expense		13,391				8,622				19,776
Interest expense, net		11,581				10,238				12,133
Other expense (income), net		4,330				878				(5,305	)
GAAP - Operating income		113,978				80,744				113,228
Operating margin - as a % of net sales		22.2	%			19.6	%			21.9	%
Charge for fair value write-up of acquired inventory sold		—				361				—
Deal and transaction costs		—				1,431				—
Integration costs		2,044				48				1,300
Severance and restructuring costs		143				843				501
Amortization of intangible assets		11,871				16,211				11,916
Adjusted operating income		128,036				99,638				126,945
Adjusted operating margin - as a % of net sales		25.0	%			24.2	%			24.5	%
Depreciation		22,095				20,648				21,366
Adjusted EBITDA	$	150,131			$	120,286			$	148,311
Adjusted EBITDA - as a % of net sales		29.3	%			29.2	%			28.7	%

Entegris, Inc. and Subsidiaries Reconciliation of GAAP Net Income and Diluted Earnings per Common Share to Non-GAAP Net Income and Diluted Non-GAAP Earnings per Common Share (In thousands, except per share data) (Unaudited)
	Three months ended
	April 3, 2021			March 28, 2020			December 31, 2020
GAAP net income	$	84,676		$	61,006		$	86,624
Adjustments to net income:
Charge for fair value write-up of inventory acquired		—			361			—
Deal and transaction costs		—			1,431			—
Integration costs		2,044	{ "@context": "https://schema.org", "@type": "FAQPage", "name": "Entegris Reports Results for First Quarter Of 2021 FAQs", "mainEntity": [ { "@type": "Question", "name": "What are Entegris' Q1 2021 financial results?", "acceptedAnswer": { "@type": "Answer", "text": "Entegris reported Q1 2021 sales of $512.8 million, a 24% increase from last year, with a GAAP net income of $84.7 million." } }, { "@type": "Question", "name": "What is Entegris' forecast for Q2 2021?", "acceptedAnswer": { "@type": "Answer", "text": "Entegris expects Q2 2021 sales between $530 million and $545 million, with diluted earnings per share projected between $0.56 and $0.61." } }, { "@type": "Question", "name": "How did Entegris perform in the semiconductor market?", "acceptedAnswer": { "@type": "Answer", "text": "Entegris observed strong demand driven by industry conditions and continues to benefit from the healthy semiconductor market." } }, { "@type": "Question", "name": "What was the non-GAAP net income for Entegris in Q1 2021?", "acceptedAnswer": { "@type": "Answer", "text": "The non-GAAP net income for Q1 2021 was $95.5 million, or $0.70 per diluted share." } }, { "@type": "Question", "name": "What factors contributed to Entegris' revenue growth in Q1 2021?", "acceptedAnswer": { "@type": "Answer", "text": "The revenue growth was primarily attributed to accelerating industry conditions and strong demand for their leading-edge solutions." } } ] } FAQ What are Entegris' Q1 2021 financial results? Entegris reported Q1 2021 sales of $512.8 million, a 24% increase from last year, with a GAAP net income of $84.7 million. What is Entegris' forecast for Q2 2021? Entegris expects Q2 2021 sales between $530 million and $545 million, with diluted earnings per share projected between $0.56 and $0.61. How did Entegris perform in the semiconductor market? Entegris observed strong demand driven by industry conditions and continues to benefit from the healthy semiconductor market. What was the non-GAAP net income for Entegris in Q1 2021? The non-GAAP net income for Q1 2021 was $95.5 million, or $0.70 per diluted share. What factors contributed to Entegris' revenue growth in Q1 2021? The revenue growth was primarily attributed to accelerating industry conditions and strong demand for their leading-edge solutions. Entegris Inc NASDAQ:ENTG ENTG Rankings #659 Ranked by Market Cap #2053 Ranked by Dividends #68 Top Loser ENTG Latest News Nov 4, 2024 Entegris Reports Results for Third Quarter of 2024 Oct 21, 2024 Entegris to Report Results for Third Quarter of 2024 on Monday, November 4, 2024 Oct 16, 2024 Entegris Declares Quarterly Cash Dividend Sep 5, 2024 Entegris Appoints Mary Puma to Board of Directors Aug 7, 2024 Entegris Enters Into Long-Term Supply Agreement with onsemi ENTG Stock Data Market Cap 15.78B Float 150.39M Insiders Ownership 0.33% Institutions Ownership 101.79% Short Percent 3.63% Industry Semiconductor Equipment & Materials Sector Plastics Products, Nec Website Link Country United States of America City BILLERICA Explore About Rhea-AI Sitemap Legal Terms of Use Cookie Notice Privacy Policy Links RSS feed Patreon Discord Server Facebook Reddit Google News © 2020-2024 StockTitan.net